XOMA Co. (NASDAQ:XOMAO) Short Interest Up 33.3% in February

XOMA Co. (NASDAQ:XOMAO) was the recipient of a large growth in short interest in February. As of February 28th, there was short interest totalling 2,800 shares, a growth of 33.3% from the February 13th total of 2,100 shares. Based on an average trading volume of 1,900 shares, the short-interest ratio is presently 1.5 days.

XOMA Stock Performance

Shares of XOMAO opened at $25.45 on Monday. XOMA has a 12 month low of $24.70 and a 12 month high of $25.87. The firm has a fifty day simple moving average of $25.36 and a 200 day simple moving average of $25.44.

About XOMA

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.